Curevac (CVAC) Revenue Breakdown: Q3 2025 Business & Regional Performance
Curevac (CVAC) reported total revenue of 71.70M USD in Q3 2025, with its core business segment GlaxoSmithKline contributing 81.83%. Regionally, Belgium remained the largest market, accounting for 14.94% of total revenue. Explore Curevac's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.